Prognostic significance of low muscle volume in patients undergoing surgery for oesophageal cancer.


Journal

Clinical nutrition ESPEN
ISSN: 2405-4577
Titre abrégé: Clin Nutr ESPEN
Pays: England
ID NLM: 101654592

Informations de publication

Date de publication:
12 2020
Historique:
received: 19 03 2020
revised: 17 08 2020
accepted: 14 09 2020
entrez: 13 11 2020
pubmed: 14 11 2020
medline: 25 9 2021
Statut: ppublish

Résumé

This study aimed to determine the prognostic significance of low muscle volume (LMV) Bioelectrical Impedance Analysis (BIA), defined skeletal muscle index (SMI, Kg/m A prospective study of 122 patients diagnosed with OC [median age 65 yr, 104 male, 65 neoadjuvant therapy] who underwent preoperative BIA (Maltron Bioscan 920). Primary outcome measure was Overall Survival (OS). LMV was identified in 11 (9.0%) of patients, which was associated with low lean muscle mass (27.3 vs. 31.1 kg, p = 0.012), low body fat (8.8 vs.19.3 kg, p < 0.001), and greater total body water (72.2 vs. 62.2%, p = 0.001), and more open & close laparotomies (36.4 vs. 8.1%, p = 0.012). Median and 5-year OS was 16 months and 18.2% in LMV patients, compared with 51 months and 52.4% in non-sarcopenic patients (p = 0.002). On multivariable analysis of pre-operative variables, only LMV (HR 2.75; 95% CI 1.33-5.66, p = 0.006) was associated with OS. BIA is an important prognostic indicator in OC and focused pre-habilitation consequently has strong potential.

Sections du résumé

BACKGROUND & AIMS
This study aimed to determine the prognostic significance of low muscle volume (LMV) Bioelectrical Impedance Analysis (BIA), defined skeletal muscle index (SMI, Kg/m
METHODS
A prospective study of 122 patients diagnosed with OC [median age 65 yr, 104 male, 65 neoadjuvant therapy] who underwent preoperative BIA (Maltron Bioscan 920). Primary outcome measure was Overall Survival (OS).
RESULTS
LMV was identified in 11 (9.0%) of patients, which was associated with low lean muscle mass (27.3 vs. 31.1 kg, p = 0.012), low body fat (8.8 vs.19.3 kg, p < 0.001), and greater total body water (72.2 vs. 62.2%, p = 0.001), and more open & close laparotomies (36.4 vs. 8.1%, p = 0.012). Median and 5-year OS was 16 months and 18.2% in LMV patients, compared with 51 months and 52.4% in non-sarcopenic patients (p = 0.002). On multivariable analysis of pre-operative variables, only LMV (HR 2.75; 95% CI 1.33-5.66, p = 0.006) was associated with OS.
CONCLUSION
BIA is an important prognostic indicator in OC and focused pre-habilitation consequently has strong potential.

Identifiants

pubmed: 33183540
pii: S2405-4577(20)30203-5
doi: 10.1016/j.clnesp.2020.09.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-225

Informations de copyright

Copyright © 2020 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Nothing to declare.

Auteurs

Arfon Powell (A)

Cardiff University, Division of Cancer and Genetics, Cardiff, Wales, United Kingdom. Electronic address: powella16@cardiff.ac.uk.

Mubashir Mulla (M)

Cardiff & Vale University Health Board, Department of Surgery, Cardiff, Wales, United Kingdom.

Catherine Eley (C)

Cardiff & Vale University Health Board, Department of Surgery, Cardiff, Wales, United Kingdom.

Neil Patel (N)

Cardiff & Vale University Health Board, Department of Surgery, Cardiff, Wales, United Kingdom.

Tarig Abdelrahman (T)

Cardiff & Vale University Health Board, Department of Surgery, Cardiff, Wales, United Kingdom.

Paul Blake (P)

Cardiff & Vale University Health Board, Department of Surgery, Cardiff, Wales, United Kingdom.

Rachael Barlow (R)

Cardiff & Vale University Health Board, Department of Surgery, Cardiff, Wales, United Kingdom.

Damian Bailey (D)

University of South Wales, Pontypridd, Wales, United Kingdom.

Wyn Lewis (W)

Cardiff & Vale University Health Board, Department of Surgery, Cardiff, Wales, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH